The Annual Regulatory Plan for 2023 recently released by the Spanish Government provides for important regulatory changes and developments in the area of medicinal products, including pricing and ...

In recent years, there has been an uptick in interest in the Chinese market from licensors based predominantly in the U.S., Canada, Europe, and South Korea. Factors encouraging the in-licensing of ...

As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened regulatory scrutiny, the role of the top pharmaceutical API manufacturer has taken on ...

Advancements in drug manufacturing technologies are reshaping global regulatory frameworks. This shift is largely driven by the integration of artificial intelligence (AI)-powered models, cloud-based ...

A loophole in prescription drug regulation exposes American consumers to false and misleading claims of drug ads via on-line businesses promoting potent drugs without accurate information about their ...

Rare Disease Day is held on the last day of February to raise awareness for rare diseases and address drug development ...

WASHINGTON — Government regulators may soon decide whether to crack down on distracting visuals in television drug commercials or require subtitles about side effects, a regulation that’s been 13 ...

The trade group Pharmaceutical Research and Manufacturers of America has filed a lawsuit in federal district court to stop HHS from implementing a regulation that would allow certain healthcare ...

The threat that any intervention not designed purely to preserve or increase private sector incentives will chill innovation is used as a hammer on policymakers to deter even modest regulatory ...

Add Yahoo as a preferred source to see more of our stories on Google. A new law regulating a federal drug discount program in Rhode Island went into effect on Wednesday, Oct. 1, after a District Court ...